Evaluación serológica del tratamiento de la enfermedad de Chagas crónica con alopurinol e itraconazol / Serologic evaluation of treatment of chronic Chagas disease with allopurinol and itraconazole
There were no differences in ELISA and indirect immunofluorescence tests before and after therapy. Antigenic recognition profiles by Western Blot showed qualitative and quantitative differences in a small number of cases. CoML showed that the greater negativity was achieved in the Chagasic group treated with allopurinol or itraconazole that had a negative xenodiagnosis before drugstreatment (35.8 and 61.6 percent, respectively).